O'FALLON, Mo., Dec. 1 /PRNewswire-FirstCall/ -- Synergetics USA, Inc.
(Nasdaq: SURG) announced today an expansion of its relationship with Mutoh
Corporation ("Mutoh"). Mutoh, through its wholly-owned subsidiary Miwatec
Co., Ltd., developed and manufactures the Sonopet Omni(R) in Japan.
Synergetics produces specialized tips for the aspirator which allow for the
ultrasonic removal of bone during neuro, gastrointestinal, urological, plastic
and reconstructive, general, orthopedic gynecological, thoracic, laparoscopic
and thoracoscopic surgery. This ultrasonic aspirator and tips are currently
sold in the United States and Canada under Synergetics' branding. The Sonopet
Omni(R) ultrasonic aspirator is the only currently marketed device approved by
the FDA for ultrasonic removal of bone. The expansion will allow Synergetics
to begin selling the Omni(R) ultrasonic aspirator and tips in all but a few
countries internationally, subject to any necessary regulatory approvals.
"We are obviously very pleased with the expansion of our relationship with
Mutoh into the international marketplace," said Gregg D. Scheller, president
and CEO of Synergetics. "The Omni(R) product goes hand-in-glove with our
Malis(R) line of electrosurgical generators and allows us considerable
marketing leverage with our blossoming lineup of international distributors."
About Synergetics USA, Inc.
Synergetics USA, Inc. resulted from the September 2005 combination of
Valley Forge Scientific Corp. and Synergetics, Inc., bringing together their
respective unique capabilities in bipolar electrosurgical generators and
design, and manufacture of microsurgical hand instruments. Synergetics USA,
Inc. designs, manufactures and markets medical devices for use primarily in
ophthalmic surgery and neurosurgery and for other healthcare applications. Its
products are designed and manufactured to support micro or minimally invasive
surgical procedures. In addition to its surgical devices and equipment, it
designs and manufactures disposable and non-disposable supplies and
accessories for use with such devices and equipment. It also manufactures and
sells bipolar electrosurgical generators and other generators, based on its
DualWave(TM) technology, and complementary instrumentation and disposable
products for use in neurosurgery, spine surgery, pain control and in dental
applications. Synergetics sells its products primarily to hospitals, clinics
and surgeons in approximately 70 countries.
Forward-Looking Statements
Some statements in this release may be "forward-looking statements" for
the purposes of the Private Securities Litigation Reform Act of 1995. In some
cases, forward-looking statements can be identified by words such as
"believe," "expect," "anticipate," "plan," "potential," "continue" or similar
expressions. Such forward-looking statements are based upon current
expectations and beliefs and are subject to a number of factors. These
forward-looking statements are subject to risks and uncertainties that may
cause actual results to differ materially from those indicated in the forward-
looking statements, including but not limited to: the effects of local and
national economic, credit and capital market conditions on the economy in
general, and on the medical device industry in particular, and the effects of
foreign exchange rates and interest rates; the ability to timely and cost-
effectively integrate the operations and management of Valley Forge and
Synergetics following their merger transaction; the ability to realize the
synergies and other perceived advantages resulting from the merger; the
ability to retain and attract key personnel; the ability of Synergetics to
successfully execute its business strategy; the extent and timing of market
acceptance of new products or product indications; the ability of Synergetics
to procure, maintain, enforce and defend its patents and proprietary know how;
changes in laws, including increased tax rates, regulations or accounting
standards, third-party relations and approvals, and decisions of courts,
regulators and governmental bodies; the ability of Synergetics to continue to
increase customer loyalty; the ability to recoup costs of capital investments
through higher revenues; environmental restrictions, soil and water
conditions, weather and other hazards, site access matters and building permit
issues; the effects of environmental and structural building conditions
relating to Synergetics' properties; acts of war or terrorism incidents; the
effects of operating and market competition; and other important factors
disclosed previously and from time to time in Synergetics' filings with the
SEC. Synergetics undertakes no obligation to update these forward-looking
statements.
Pamela G. Boone
Chief Financial Officer
Synergetics USA, Inc.
(636) 939-5100
http://www.synergeticsusa.com
SOURCE Synergetics USA, Inc.
 back to top
Related links:
http://www.synergeticsusa.com
CONTACT:
Pamela G. Boone, Chief Financial Officer,
Synergetics USA, Inc., +1-636-939-5100
|
